Skip to main content
OpenTrials
Completed

NCT Number: NCT06501014

Effectiveness of Action Observation Therapy in Stroke Patients

The goal of this clinical trial is to learn the effectiveness of action observation therapy in patients with stroke.

The main questions it aims to answer are:

Is action observation therapy an effective method in stroke patients?

Researchers will compare the results of two action observation-based exercises (home program) with conventional exercise to see whether action observation therapy works in the rehabilitation of stroke patients.

Participants:

Participants in one group will do action observation-based exercise (home plus conventional exercise for 24 sessions, Patients in the control group will only undergo conventional exercise in addition to routine treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KTO Karatay University

Konya, Turkey (Türkiye)

About this study

Individuals with chronic stroke will be included in this study. Participants will be randomly divided into two groups, and patients in both groups will continue their routine treatments.

Patients in the control group will only undergo conventional exercise. Patients in the study group will be given a home exercise program in addition to conventional treatment. However, patients will be asked to first watch the video of each exercise in this program and then perform the exercise.

Patients will be asked to perform the exercises 3 days a week for 8 weeks. Evaluations will be made twice, before the exercise program application begins and after the sessions are completed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stroke patients in the chronic phase (more than 6 months have passed since the stroke)
  • Patients over 40 years of age
  • Patients who can stand and walk independently (including those using walking aids)

Exclusion criteria

  • Additional disease (neurological, orthopedic, etc.) that may affect motor performance and balance.
  • Patients with communication problems
  • Patients with mental problems (mini-mental test score <23)
  • Patients aged 85 and over

Treatment and study plan

Action Observation Therapy-Experimental Group

Other

Patients will be asked to watch the exercises before doing them.For each exercise, patients will first watch the relevant video and do the exercise after the video ends.

Conventional Exercises-Control Group

Other

Patients will be subjected to conventional exercise only.

Primary outcomes

  1. 2 minute walk test

    Time frame: The evaluation will be applied at the baseline and after study completion, an average of 2 months.

    Patients will be asked to walk 30 meters long on a flat surface for 2 minutes. When the time is up, the distance the patient can walk will be recorded.

  2. Fugl-Meyer Assessment

    Time frame: The evaluation will be applied at the baseline and after study completion, an average of 2 months.

    The FMA motor assessments for the lower extremity (minimum score:0 and maximum score 34 points) will be applied. A higher score means the patient's motor movements are better.

  3. Berg Balance Scale

    Time frame: The evaluation will be applied at the baseline and after study completion, an average of 2 months.

    The Berg Balance Scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of funcion.

Sponsors and collaborators

Lead sponsor

KTO Karatay University

Other

Registry information

Official study title

Investigating the Effectiveness of Action Observation Therapy Applied in Addition to Conventional Treatment in Stroke Patients

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 15, 2024
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.